Smith & Nephew
Corporate

Select your country

Smith & Nephew

Advanced Search
  • Home
  • About Us
  • Innovation & Products
  • Sustainability
  • Investor Centre
  • News & Media
  • Careers
  • Home
  • Sustainability
  • Policies and Principles
  • Social Responsibility Principles
  • R&D:Stem Cells
  • Home >
  • Sustainability >
  • Policies and Principles >
  • Social Responsibility Principles >
  • R&D:Stem Cells
  • Code of Business Principles
  • Management Principles
  • People Principles
  • Ethics and Compliance
  • Whistleblowing Policy
  • Patients: Pre-clinical testing
  • R&D:Stem Cells
  • Contact
  • Print
  • Forward

Email this page

close
  1. Mandatory fields are marked with an asterisk [*].

    Tell us who you want to send your mail to Fill in your email details

    Note: Smith & Nephew does not collect or make use of the email addresses or names provided here. They are only used to show the recipient who has sent the message.

    Change your message if you want Change the message if you want to

    1. <recipient name> <address>
    2. <sender name> <address>
    3. <sender name> is sending you a link

    4. <sender name>

    Visitor verfication

Email sent successfully
Error: Check all fields are valid. Exclude special characters from Comments field
Smith
Nephew

R&D:Stem Cells

We do not currently use or have any intention of using embryonic stem cells in our research as we do not see any exclusive patient benefits from their use within our chosen fields of orthopaedic reconstruction and trauma, endoscopy and advanced wound management. Our approach has focused exclusively on the use of adult progenitor cells to accelerate repair of damaged tissue.

  • ◊ Trademark of Smith & Nephew
  • Accessibility
  • Terms of Use
  • Copyright & Disclaimer